Stockscreener 앱 받기
1.22
5.17%
0.06
시간 외 거래:
1.23
0.01
+0.82%
Mindwalk Holdings Corp 주식(HYFT)의 최신 뉴스
ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) Q3 2026 earnings call transcript - MSN
Benchmark reiterates Speculative Buy on MindWalk Holdings stock By Investing.com - Investing.com Canada
Benchmark reiterates Speculative Buy on MindWalk Holdings stock - Investing.com
ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q3 2026 Earnings Call Transcript - Insider Monkey
H.C. Wainwright reiterates Buy on MindWalk stock on SaaS deal - Investing.com Nigeria
MindWalk Holdings Corp (HYFT) Q3 2026 Earnings Call Highlights: Revenue Surge and Strategic Shifts By GuruFocus - Investing.com Canada
MindWalk Holdings Corp (HYFT) Q3 2026 Earnings Call Highlights: Revenue Surge and Strategic Shifts - GuruFocus
MindWalk Holdings Corp. (HYFT) reports Q3 loss, lags revenue estimates - MSN
MindWalk Holdings Corp. 2026 Q3ResultsEarnings Call Presentation (NASDAQ:HYFT) 2026-03-12 - Seeking Alpha
MindWalk Holdings Corp. Q3 2026 Earnings Call Summary - Yahoo Finance
MindWalk (HYFT) Q3 2026 Earnings Call Transcript - The Globe and Mail
HYFT: Q3 revenue up 52% YoY, recurring LensAI contract signed, and pipeline programs advanced - TradingView
MindWalk Holdings Corp. (HYFT) Posts Third Quarter Loss, Falls Short of Revenue Expectations - Bitget
HYFT: Q3 FY 2026 revenue rose 52% YoY, with first enterprise contract and $14.2M cash on hand - TradingView
Q3 2026 MindWalk Holdings Corp Earnings Call Transcript - GuruFocus
MindWalk Holdings Corp. (HYFT) Reports Q3 Loss, Lags Revenue Estimates - Yahoo Finance
MindWalk Holdings Corp reports results for the quarter ended January 31Earnings Summary - TradingView
MindWalk Holdings Delivers Q3 Revenue Surge and Secures First LensAI Platform Contract - TipRanks
HYFT: Q3 revenue up 52% to $4.2M, with recurring contracts and pipeline progress boosting outlook - TradingView
MindWalk Holdings (NASDAQ: IPA) grows revenue 45% and boosts margins amid AI pivot - Stock Titan
MindWalk Holdings Corp. Reports Q3 Fiscal 2026 Financial Results - The Joplin Globe
MindWalk Holdings Corp. (Nasdaq: HYFT) posts 52% Q3 revenue growth - Stock Titan
AI biotech MindWalk targets dengue, obesity and flu with llama nanobodies - Stock Titan
HYFT Forecast, Price Target & Analyst Ratings | MINDWALK HOLDINGS CORP (NASDAQ:HYFT) - ChartMill
MindWalk Holdings emphasizes AI-driven strategy in latest financial release - MSN
MindWalk Holdings Corp PE Ratio (TTM) & PE Ratio (TTM) ChartsHYFT - GuruFocus
MindWalk launches nanobody discovery platform for bispecifics - Investing.com Nigeria
MindWalk Holdings Corp expected to post a loss of 5 cents a shareEarnings Preview - TradingView
MindWalk launches nanobody discovery platform for bispecifics By Investing.com - Investing.com Australia
HYFT Stock Price and Chart — NASDAQ:HYFT - TradingView
MindWalk Announces B Cell Llama(TM), a Nanobody Discovery Platform Designed for the Bispecific and Cell Therapy Era - irw-press.com
MindWalk Announces B Cell Llama™, a Nanobody Discovery Platform Designed for the Bispecific and Cell Therapy Era - The National Law Review
MindWalk (HYFT) Introduces B Cell Llama for Enhanced Antibody Di - GuruFocus
MindWalk Unveils B Cell Llama Nanobody Platform Backed by Peer-Reviewed Study - TipRanks
New MindWalk (NASDAQ: HYFT) B Cell Llama platform targets bispecific and cell therapies - Stock Titan
HYFT SEC FilingsMindWalk Holdings Corp 10-K, 10-Q, 8-K Forms - Stock Titan
MindWalk Holdings to Report Q3 2026 Earnings - National Today
MindWalk Holdings Corp. to Report Third Quarter Fiscal Year 2026 Financial Results on March 12, 2026 - 01net
MindWalk Sets March 12 Date to Report Q3 2026 Results and Host Earnings Webcast - TipRanks
MindWalk (NASDAQ: IPA) sets March 12 call on Q3 FY 2026 results - Stock Titan
HYFT Technical Analysis & ETF Price Forecast - Intellectia AI
Zacks Research Upgrades MindWalk (NASDAQ:HYFT) to Hold - MarketBeat
Technology to Detect Functional Adjacency Linked to Portfolio Risk in AI-Designed Therapeutics - Business Wire
MindWalk Uses HYFT AI Platform to Expose Hidden Portfolio and IP Risks in Drug Discovery - TipRanks
MindWalk Applies HYFT® Technology to Detect Functional Adjacency Linked to Portfolio Risk in AI-Designed Therapeutics - Yahoo Finance
MindWalk Launches HYFT Technology to Address Drug Development Risks - intellectia.ai
HYFT Forecast — Price Prediction for 2026. Should I Buy HYFT? - Intellectia AI
After Leaping 47% MindWalk Holdings Corp. (NASDAQ:HYFT) Shares Are Not Flying Under The Radar - 富途牛牛
MindWalk Validates Platform Precision with Breakthrough Discovery Targeting Pathogenic TDP-43 in Neurodegenerative Disease - BioSpace
Mindwalk Validates Platform Precision with Breakthrough Discovery Targeting Pathogenic Tdp-43 in Neurodegenerative Disease - marketscreener.com
1.20%
0.06%
자본화:
|
볼륨(24시간):